Secretin vs BI 456906
Head-to-head comparison of Secretin (Human Secretin) and BI 456906 (BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.
| Property | Secretin | BI 456906 |
|---|---|---|
| Category | Gastrointestinal | Weight Management |
| Full Name | Human Secretin | BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist |
| Molecular Weight | 3055.4 Da | N/A |
| Half-Life | 5-7 minutes | Approximately 1 week |
| Amino Acids | 27 | N/A |
| Typical Dose | 0.2 mcg/kg IV | Trial-dependent; weekly SC dosing |
| Route | Intravenous | Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 800 | 10 |
| Research Status | Clinical | Clinical |
Secretin Benefits
- ✓stimulates-pancreatic-secretion
- ✓supports-bicarbonate-release
- ✓aids-duodenal-pH-control
- ✓helps-digestive-coordination
BI 456906 Benefits
- ✓weight reduction
- ✓improved glucose control
- ✓lower liver-fat burden
- ✓enhanced satiety
Secretin Dosing
0.2 mcg/kg IV diagnostic dose|research infusion protocols|short bolus administration
BI 456906 Dosing
once-weekly subcutaneous injection|stepwise titration|ongoing maintenance phase
Secretin Side Effects
- ⚠flushing
- ⚠nausea
- ⚠abdominal-cramping
BI 456906 Side Effects
- ⚠nausea
- ⚠abdominal discomfort
- ⚠diarrhea
Research Overview
Secretin
Secretin is a classic GI hormone with extensive physiology literature and established diagnostic use. It remains important for studying pancreatic secretory function, biliary responses, and duodenal feedback.
BI 456906
Preclinical and early clinical research support meaningful metabolic effects with a tolerable safety profile. It remains investigational and is not commercially available.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.